• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Dr. Reddy's Laboratories Limited — Important, 31-12-2025: Updates

    31-12-2025 | 07:53 pm

    Dr. Reddy's subsidiary received a USFDA Complete Response Letter for its biosimilar AVT03 (denosumab). The letter cites observations from an inspection of Alvotech's manufacturing facility, delaying potential market entry.

    No comments yet. Be the first to comment!

    All announcements from Dr. Reddy's Laboratories Limited